Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure

Toxicology and Applied Pharmacology

Volumn 191, Issue 1, 2003, Pages 12-21

  Kim, Amy H ^a,b   Kohn, Michael C ^b   Nyska, Abraham ^b   Walker, Nigel J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Carcinogenesis; Dioxins; Dosimetry; Risk assessment

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CORN OIL; DRUG VEHICLE; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; FEEDING; FEMALE; LIVER LEVEL; NONHUMAN; PLACENTA; RAT; TISSUE LEVEL; TOXICOKINETICS;

ZEA MAYS;

EID: 0043065286     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00225-4     Document Type: Article

References (33)

1. Campbell H., Pitot H.C., Potter V.R., Laishes B.A. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 42:1982;465-472.
2. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Molecular origin of cancer catechol estrogen-3,4-quinones as endogenous tumor initiators . Proc. Natl. Acad. Sci. USA. 94:1997;10937-10942.
3. Christensen J.G., Romach E.H., Healy L.N., Gonzales A.J., Anderson S.P., Malarkey D.E., Corton J.C., Fox T.R., Cattley R.C., Goldsworthy T.L. Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice. Carcinogenesis. 20:1999;1583-1590.
4. Devito M.J., Ma X.F., Babish J.G., Menache M., Birnbaum L.S. Dose-response relationships in mice following subchronic exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin Cyplal, Cypla2, estrogen-receptor, and protein-tyrosine phosphorylation . Toxicol. Appl. Pharmacol. 124:1994;82-90.
5. Fingerhut M.A., Halperin W.E., Marlow D.A., Piacitelli L., Honchar P.A., Sweeny M.H., Griefe A.L., Dill P.A., Steenland K., Suruda H. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 324:1991;212-218.
6. Hays S.M., Aylward L.L., Karch N.J., Paustenbach D.J. The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-TCDD an analysis using standard and internal measures of dose . Chemosphere. 34:1997;1507-1522.
7. Higuchi R., Dollinger G., Walsh P.S., Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology. 10:1992;413-417.
8. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis real-time monitoring of DNA amplification reactions . Biotechnology. 11:1993;1026-1030.
9. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., Humiston C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46:1978;279-303.
10. Kohn M.C., Sewall C.H., Lucier G.W., Portier C.J. A mechanistic model of effects of dioxin on thyroid hormones in the rat. Toxicol. Appl. Pharmacol. 136:1996;29-48.
11. Kohn M.C., Walker N.J., Kim A.H., Portier C.J. Physiological modeling of a proposed mechanism of enzyme induction by TCDD. Toxicology. 162:2001;193-208.
12. Lucier G.W., Tritscher A., Goldsworthy T., Foley J., Clark G., Goldstein J., Maronpot R. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 51:1991;1391-1397.
13. Maronpot R.R., Foley J.F., Takahashi K., Goldsworthy T., Clark G., Tritscher A., Portier C., Lucier G. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN histologic, biochemical, and cell proliferation endpoints . Environ. Health Perspect. 101:1993;634-642.
14. Martucci C.P., Fishman J. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57:1993;237-257.
15. Risk Assessment in the Federal Government Managing the Process . 1983;National Academy Press, Washington, DC.
16. Pitot H.C. Altered hepatic foci their role in murine hepatocarcinogenesis . Annu. Rev. Pharmacol. Toxicol. 30:1990;465-500.
17. Pitot H.C., Dragan Y.P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 5:1991;2280-2286.
18. Pitot H.C., Goldsworthy T., Campbell H.A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40:1980;3616-3620.
19. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons examination of the mechanism of toxicity . Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
20. Pugh T.D., King J.H., Koen H., Nychka D., Chover J., Wahba G., He Y., Goldfarb S. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res. 43:1983;1261-1268.
21. Reyes H., Reisz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science. 256:1992;1193-1195.
22. Roy D., Bernhardt A., Strobel H.W., Liehr J.G. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. Arch. Biochem. Biophys. 296:1992;450-456.
23. Stinchcombe S., Buchmann A., Bock K.W., Schwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin mediated tumor promotion. Carcinogenesis. 16:1995;1271-1275.
24. Tritscher A.M., Goldstein J.A., Portier C.J., McCoy Z., Clark G.C., Lucier G.W. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat-tumor promotion model quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver . Cancer Res. 52:1992;3436-3442.
25. Vanden Heuvel J.P., Clark G.C., Kohn M.C., Tritscher A.M., Greenlee W.F., Lucier G.W., Bell D.A. Dioxin-responsive genes examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction . Cancer Res. 54:1994;62-68.
26. Walker N.J. Real-time and quantitative PCR applications to mechanism-based toxicology . J. Biochem. Mol. Toxicol. 15:2001;121-127.
27. Walker N.J., Miller B.D., Kohn M.C., Lucier G.W., Tritscher A.M. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver. Carcinogenesis. 19:1998;1427-1435.
28. Walker N.J., Portier C.J., Lax S.F., Crofts F.G., Li Y., Lucier G.W., Sutter T.R. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 154:1999;279-286.
29. Walker N.J., Tritscher A.M., Sills R.C., Lucier G.W., Portier C.J. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 54:2000;330-337.
30. Whitlock J.P. The regulation of gene expression by 2,3,7,8-tetrachlorodiobenzo-p-dioxin. Pharmacol. Rev. 39:1987;147-161.
31. Wyde M.E., Eldridge S.R., Lucier G.W., Walker N.J. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced tumor promotion by 17 beta-estradiol in female Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 173:2001;7-17.
32. Wyde M.E., Wong V.A., Kim A.H., Lucier G.W., Walker N.J. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent. Chem. Res. Toxicol. 14:2001;849-855.
33. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36:1996;203-232.